Welcome to CDC stacks | The Costly burden of drug-resistant TB in the United States - 22071 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Costly burden of drug-resistant TB in the United States
  • Published Date:
    March 2014
  • Language:
    English
Filetype[PDF-1.88 MB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
  • Description:
    Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR). This infographic highlights that while MDR and XDR TB are relatively rare in the U.S., their treatment comes at a terrible price – it is very expensive, takes a long time to treat, disrupts lives, and has potentially life-threatening side effects.

  • Document Type:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: